In continuation to its letter dated May 11, 2021, Novartis India has informed that the Board of Directors of the Company has in its meeting held today, on Thursday, June 17, 2021 (‘said meeting’), have approved: Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2021, recommendation of final dividend of Rs 10 per Equity share of Rs 5 each for the year ended March 31, 2021, subject to approval of the shareholders of the Company, date for convening the 73rd Annual General Meeting of the shareholders of the Company is scheduled to be held on Friday, August 27, 2021 at 11:30 am through Video conference/ Other Audio Visual Means; and closure of Register of Members and Share Transfer books from Friday, August 20, 2021 to Friday, August 27, 2021 for determining the eligibility of shareholders for payment of Dividend. The said Meeting commenced at 11:00 am and concluded at 3.30 pm. Further, pursuant to Regulation 33 of the SEBI Listing Regulations, the company has enclosed: Audited Financial Results for the quarter and year ended March 31, 2021, Auditors Report dated June 17, 2021, issued by the Statutory Auditors of the Company with respect to the Audited Financial Results and taken on record by the Board of Directors of the Company and Declaration on unmodified opinion on Audit Report. The above is for the information and the same is also available on the Company's website: www.novartis.in.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Redington | 193.45 |
Adani Enterprises | 2825.90 |
Amrapali Industries | 17.81 |
Rashi Peripheral | 369.15 |
Compuage Infocom | 2.71 |
View more.. |